Jakob Gebel

813 total citations · 1 hit paper
19 papers, 535 citations indexed

About

Jakob Gebel is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Jakob Gebel has authored 19 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Biotechnology. Recurrent topics in Jakob Gebel's work include Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (5 papers) and Ubiquitin and proteasome pathways (5 papers). Jakob Gebel is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (5 papers) and Ubiquitin and proteasome pathways (5 papers). Jakob Gebel collaborates with scholars based in Germany, United Kingdom and United States. Jakob Gebel's co-authors include Volker Dötsch, Marcel Tuppi, Gerry Melino, Gerhard Hummer, Stefan Knapp, Daniel Coutandin, Sebastian Kehrloesser, Christian Osterburg, Frank Löhr and Ute M. Moll and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Molecular Cell.

In The Last Decade

Jakob Gebel

19 papers receiving 529 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation

2022 120 citations Lara A. Gruijs da Silva, Francesca Simonetti et al. The EMBO Journal profile →

Peers

Countries citing papers authored by Jakob Gebel

Since Specialization

Citations

This map shows the geographic impact of Jakob Gebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakob Gebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakob Gebel more than expected).

Fields of papers citing papers by Jakob Gebel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakob Gebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakob Gebel. The network helps show where Jakob Gebel may publish in the future.

Co-authorship network of co-authors of Jakob Gebel

This figure shows the co-authorship network connecting the top 25 collaborators of Jakob Gebel. A scholar is included among the top collaborators of Jakob Gebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakob Gebel. Jakob Gebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	DARPins as a novel tool to detect and degrade p73 2024 ·Cell Death and Disease ·(unknown), Jan M. Zielinski, Alexander Strubel, (unknown), Birgit Dreier, Jonas V. Schaefer, Birgit Schäfer, Jakob Gebel, Christian Osterburg, A. Chaikuad, Stefan Knapp, Andreas Plückthun, Volker Dötsch	1
2	DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma 2023 ·Cell Death and Disease ·Alexander Strubel, (unknown), Oliver Hartmann, A. Chaikuad, Birgit Dreier, Jonas V. Schaefer, Jakob Gebel, Christian Osterburg, Marcel Tuppi, Birgit Schäfer, (unknown), Mathias T. Rosenfeldt, Stefan Knapp, Andreas Plückthun, Markus E. Diefenbacher, Volker Dötsch	7
3	Deconstructing Protein Binding of Sulfonamides and Sulfonamide Analogues 2023 ·SHILAP Revista de lepidopterología ·(unknown), Christian Meyners, (unknown), (unknown), Frank Löhr, Jakob Gebel, Thomas Nehls, Volker Dötsch, Frederik Lermyte, Felix Hausch	10
4	Fuzzy interactions between the auto-phosphorylated C-terminus and the kinase domain of CK1δ inhibits activation of TAp63α 2023 ·Scientific Reports ·(unknown), Jakob Gebel, (unknown), (unknown), Süleyman Bozkurt, (unknown), Frank Löhr, Christian Münch, Volker Dötsch	5
5	Disease‐linked TDP‐43 hyperphosphorylation suppresses TDP‐43 condensation and aggregation breakdown → 2022 ·The EMBO Journal ·Lara A. Gruijs da Silva, Francesca Simonetti, Saskia Hutten, Henrick Riemenschneider, Erin L. Sternburg, Lisa M. Pietrek, Jakob Gebel, Volker Dötsch, Dieter Edbauer, Gerhard Hummer, Lukas S. Stelzl, Dorothee Dormann	120
6	Designed Ankyrin Repeat Proteins as a tool box for analyzing p63 2022 ·Cell Death and Differentiation ·Alexander Strubel, (unknown), A. Chaikuad, Birgit Dreier, Jonas V. Schaefer, Jakob Gebel, Christian Osterburg, Marcel Tuppi, Birgit Schäfer, Stefan Knapp, Andreas Plückthun, Volker Dötsch	6
7	Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes 2022 ·Molecular Cell ·(unknown), A. Chaikuad, Jun‐Song Chen, Jakob Gebel, Laura Tesmer, (unknown), José Navarrete-Perea, (unknown), Steven P. Gygi, Gerhard Hummer, Volker Dötsch, Stefan Knapp, Kathleen L. Gould	17
8	Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders 2021 ·Journal of Medicinal Chemistry ·(unknown), Bikash Adhikari, Andreas Krämer, (unknown), (unknown), Lena M. Berger, (unknown), Magdalena M. Szewczyk, Dalia Baršytė-Lovejoy, C.H. Arrowsmith, Jakob Gebel, Frank Löhr, Volker Dötsch, Martin Eilers, Stephanie Heinzlmeir, Bernhard Küster, Christoph Sotriffer, Elmar Wolf, Stefan Knapp	48
9	Discovery of Protein-Protein Interaction Inhibitors by Integrating Protein Engineering and Chemical Screening Platforms 2020 ·Cell chemical biology ·Timurs Maculins, Javier García‐Pardo, (unknown), Jakob Gebel, Mateusz Putyrski, (unknown), (unknown), (unknown), Maria Kuzikov, Andrea Zaliani, Simin Rahighi, Véronique Schaeffer, Michael J. Parnham, Sachdev S. Sidhu, Andreas Ernst, Volker Dötsch, Masato Akutsu, Ivan Đikić	13
10	p63 uses a switch-like mechanism to set the threshold for induction of apoptosis 2020 ·Nature Chemical Biology ·Jakob Gebel, Marcel Tuppi, A. Chaikuad, Katharina Hötte, Martin Schröder, Laura Schulz, Frank Löhr, (unknown), (unknown), Erik Henrich, (unknown), (unknown), Francesco Pampaloni, Gerhard Hummer, Ernst H. K. Stelzer, Stefan Knapp, Volker Dötsch	35
11	DNA Damaged Induced Cell Death in Oocytes 2020 ·Molecules ·Jakob Gebel, Marcel Tuppi, Nicole Sänger, Björn Schumacher, Volker Dötsch	38
12	TAp63 and GTAp63 achieve tighter transcriptional regulation in quality control by converting an inhibitory element into an additional transactivation domain 2019 ·Cell Death and Disease* ·(unknown), Christian Osterburg, Jakob Gebel, Georg Tascher, Birgit Schäfer, Huiqing Zhou, Christian Münch, Volker Dötsch	11
13	Towards complete polypeptide backbone NH assignment via combinatorial labeling 2019 ·Journal of Magnetic Resonance ·Frank Löhr, Jakob Gebel, Erik Henrich, Christopher Hein, Volker Dötsch	5
14	Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain 2018 ·Structure ·(unknown), Jakob Gebel, (unknown), Marcel Tuppi, Frank Löhr, Birgit Schäfer, Joachim Koch, Peter Güntert, Volker Dötsch, Sebastian Kehrloesser	19
15	Control mechanisms in germ cells mediated by p53 family proteins 2017 ·Journal of Cell Science ·Jakob Gebel, Marcel Tuppi, (unknown), Daniel Coutandin, (unknown), Sebastian Kehrloesser, Christian Osterburg, Volker Dötsch	26
16	Non-oncogenic roles of TAp73: from multiciliogenesis to metabolism 2017 ·Cell Death and Differentiation ·Alice Nemajerová, Ivano Amelio, Jakob Gebel, Volker Dötsch, Gerry Melino, Ute M. Moll	59
17	Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level 2016 ·eLife ·Daniel Coutandin, Christian Osterburg, Ratnesh Kumar Srivastav, (unknown), Sebastian Kehrloesser, Jakob Gebel, Marcel Tuppi, (unknown), Birgit Schäfer, E. Salah, Sebastian Mathea, (unknown), James Doutch, Manuel Grez, Stefan Knapp, Volker Dötsch	53
18	Mechanism of TAp73 inhibition by ΔNp63 and structural basis of p63/p73 hetero-tetramerization 2016 ·Cell Death and Differentiation ·Jakob Gebel, Laura M. Luh, Daniel Coutandin, Christian Osterburg, Frank Löhr, Birgit Schäfer, (unknown), (unknown), Lena Buchner, T. Krojer, E. Salah, Sebastian Mathea, Peter Güntert, Stefan Knapp, Volker Dötsch	28
19	Analysis of the oligomeric state and transactivation potential of TAp73α 2013 ·Cell Death and Differentiation ·Laura M. Luh, Sebastian Kehrloesser, (unknown), Jakob Gebel, Daniel Coutandin, B Schäfer, Massimiliano Agostini, Gerry Melino, Volker Dötsch	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact